Cholesterol & Lipid
Sort by:
National Lipid Association
Is Our Destiny Written for FH and Lp(a)?
FEATURING
Joshua Knowles
- 2,048 views
- October 11, 2023
- 10
ASPC 2020 Virtual Summit on CVD Prevention
Integrating Imaging & Advanced Blood Testing for CVD Prevention/Management: How Do We Know If the Patient Is in Prediabetes Phase? Why Do Lipoproteins Become Atherogenic? What Is the Role of Non-Lifestyle Genetic Markers?
FEATURING
Arthur Agatston
- 483 views
- March 24, 2021
- 3
National Lipid Association
Primary Prevention: A Primer on Cholesterol Screening and Treatment of Hypercholesterolemia in Youth
FEATURING
Don P. Wilson
- 813 views
- October 11, 2023
- 11
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
Role of Inflammation in Cardiovascular Disease
FEATURING
Maria Rosa Costanzo
- 692 views
- March 6, 2024
- 10
Complex Coronary Cases
Eliminating Coronary Artery Disease
FEATURING
Marc Sabatine
- 1,182 views
- August 31, 2023
- 10
Cleveland Clinic | 12th Annual Obesity Summit
Management of Hypertension and Hyperlipidemia in Type 2 Diabetes
FEATURING
Steven Nissen
- 2,153 views
- December 3, 2017
- 8
Advances in Cardiovascular Disease Prevention
Paradigm Shifts: Understanding and Applying the Latest Lipid Guidelines
FEATURING
Andrew Freeman
- 1,336 views
- October 22, 2018
- 6
Matthew Budoff
LDL Lowering and CV Risk: What to Consider When Working to Reduce Patients' LDL Cholesterol?
- 255 views
- December 3, 2020
- 1
Complex Coronary Valvular and Vascular Cases Conference
Can Coronary Artery Disease Be Eliminated In Our Lifetime?
- 1,166 views
- November 14, 2017
- 7
Texas Cardiovascular Innovations Conference 2021
Predicting Your Heart Attack Risk by Detecting Invisible Coronary Inflammation
FEATURING
Ronak Rajani
- 4,196 views
- March 2, 2022
- 22
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
Novelties in Lipid Lowering Therapies: Can Statin Therapy Reduce Residual Risk? How Promising Are Icosapent Ethyl, Bampedoic Acid, Inclisiran and Evinacumab for Treating the Patients?
FEATURING
Pam Taub
- 924 views
- February 5, 2021
- 11
Naveed Sattar
Can Empagliflozin Successfully Treat T2D Whilst Preventing Heart Failure and Protecting Renal Function?
- 819 views
- November 25, 2020
- 3
Canadian Collaborative Research Network
Approaching a Decade of PCSK9 Inhibition: Effects on CV Mortality
FEATURING
Milan Gupta
- 398 views
- July 26, 2023
- 2
ACC 2022 Conference Coverage
ACC 2022: A Single Ascending Dose Study of an siRNA Targeting Lipoprotein(a)
FEATURING
Steven Nissen
- 1,428 views
- April 11, 2022
- 16
National Lipid Association
Targeting Inflammation to Prevent Cardiovascular Disease - Ready for Prime Time?
FEATURING
Michael Garshick
- 3,015 views
- October 11, 2023
- 20
Scripps Health
Lipids Update: Overview of Current Guidelines for Lipid Management
FEATURING
David Cork
- 1,616 views
- June 14, 2023
- 7
National Lipid Association
Preventative Healthcare for Children with Dyslipidemia - Unique Opportunities and Challenges
FEATURING
Amy Peterson
- 395 views
- March 25, 2019
- 1
ASPC 2018 Congress on CVD Prevention
Debate – Pro – Lipoprotein(a) – Should Be Measured In All Patients At Higher CVD Risk
FEATURING
Patrick Moriarty
- 834 views
- August 10, 2018
- 10
National Lipid Association
The Ketogenic Diet - Where Does the Evidence Stand for ASCVD risk?
FEATURING
Carol Kirkpatrick
- 3,869 views
- March 25, 2019
- 19
ASPC 2019 Congress on CVD Prevention
Unraveling the Mysteries of Heart Disease: Lessons from the 70 Year Legacy of the Framingham Heart Study
FEATURING
Daniel Levy
- 396 views
- August 9, 2019
- 3
National Lipid Association
Lessons Learned from REDUCE-IT, STRENGTH, PROMINENT; Informing Guidelines
FEATURING
Anandita Kulkarni
- 1,381 views
- October 11, 2023
- 4